Publication: 4364

Publication: 4364

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Breast Cancer Res Treat vol 203 (3) 497-509

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: Diogo Martins-Branco Marie Kassapian Véronique Debien Rafael Caparica Daniel Eiger Urania Dafni Charitini Andriakopoulou Sarra El-Abed Susan L. Ellard Miguel Izquierdo Malou Vicente Saranya Chumsri Martine Piccart-Gebhart Alvaro Moreno-Aspitia Ann Søegaard Knop Janine Lombard Evandro de Azambuja

Networks:

Study: ALTTO
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: